Portal de Periódicos da CAPES

Marginal versus Standard Donors in Heart Transplantation: Proper Selection Means Heart Transplant Benefit

2022; Multidisciplinary Digital Publishing Institute; Volume: 11; Issue: 9 Linguagem: Inglês

10.3390/jcm11092665

2077-0383

Olimpia Bifulco, Tomaso Bottio, Raphael Caraffa, Massimiliano Carrozzini, Alvise Guariento, Jonida Bejko, Marny Fedrigo, Chiara Castellani, Giuseppe Toscano, Giulia Lorenzoni, Vincenzo Tarzia, Darío Gregori, Massimo Cardillo, Francesca Puoti, Giuseppe Feltrin, Annalisa Angelini, Gino Gerosa,

Mechanical Circulatory Support Devices

In this study, we assessed the mid-term outcomes of patients who received a heart donation from a marginal donor (MD), and compared them with those who received an organ from a standard donor (SD).All patients who underwent HTx between January 2012 and December 2020 were enrolled at a single institution. The primary endpoints were early and long-term survival of MD recipients. Risk factors for primary graft failure (PGF) and mortality in MD recipients were also analyzed. The secondary endpoint was the comparison of survival of MD versus SD recipients.In total, 238 patients underwent HTx, 64 (26.9%) of whom received an organ from an MD. Hospital mortality in the MD recipient cohort was 23%, with an estimated 1 and 5-year survival of 70% (59.2-82.7) and 68.1% (57.1-81), respectively. A multivariate analysis in MD recipients showed that decreased renal function and increased inotropic support of recipients were associated with higher mortality (p = 0.04 and p = 0.03). Cold ischemic time (p = 0.03) and increased donor inotropic support (p = 0.04) were independent risk factors for PGF. Overall survival was higher in SD than MD (85% vs. 68% at 5 years, log-rank = 0.008). However, risk-adjusted mortality (p = 0.2) and 5-year conditional survival (log-rank = 0.6) were comparable.Selected MDs are a valuable resource for expanding the cardiac donor pool, showing promising results. The use of MDs after prolonged ischemic times, increased inotropic support of the MD or the recipient and decreased renal function are associated with worse outcomes.